Mindfulness for central serous chorioretinopathy
Part of Eyes & vision clinical trials.
This study tests whether mindfulness practices can help people with central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It aims to see if mindfulness reduces stress and improves recovery compared to usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a confirmed diagnosis of central serous chorioretinopathy with active fluid in the central vision area.
- Your current episode must have started within the last 6 months.
- You haven't had certain treatments for this condition in the past (like PDT, laser, or recent eye injections).
- You do not practice meditation or mindfulness more than twice a week currently or in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This trial tests whether taking oral melatonin can help people with acute central serous chorioretinopathy, a condition where fluid builds up under the retina and causes blurred vision. If effective, this simple treatment might help improve vision and speed up recovery.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.
This study uses special eye scans to look at the back of the eye in people with central serous chorioretinopathy (a condition where fluid builds up under the retina). It aims to understand the condition better and may help guide future treatments.
This study tests a medicine called faricimab, which is given as an eye injection, to see if it helps people with a chronic eye condition that causes fluid buildup under the retina. The trial compares faricimab to a sham (fake) treatment to see if it improves vision.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.